Influence of the route of administration on targetting of ovarian cancer with chimeric monoclonalantibody Mov18: the intravenous versus intraperitoneal route

I. van Zanten-Przybysz; C.F. Molthoff; J.C. Roos; RHM Verheijen; A. van Hof; M.R. Buist; H.M. Prinssen; W. den Hollander; P. Kenemans

Influence of the route of administration on targetting of ovarian cancer with chimeric monoclonalantibody Mov18: the intravenous versus intraperitoneal route

I. van Zanten-Przybysz, C.F. Molthoff, J.C. Roos, RHM Verheijen, A. van Hof, M.R. Buist, H.M. Prinssen, W. den Hollander, P. Kenemans

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Pages (from-to)	106-114
Journal	International Journal of Cancer
Volume	92
Publication status	Published - 2001

Cite this

@article{ee3b2d64d5324776a54cba5754c98624,

title = "Influence of the route of administration on targetting of ovarian cancer with chimeric monoclonalantibody Mov18: the intravenous versus intraperitoneal route",

author = "{van Zanten-Przybysz}, I. and C.F. Molthoff and J.C. Roos and RHM Verheijen and {van Hof}, A. and M.R. Buist and H.M. Prinssen and {den Hollander}, W. and P. Kenemans",

year = "2001",

language = "English",

volume = "92",

pages = "106--114",

journal = "International Journal of Cancer",

issn = "0020-7136",

publisher = "John Wiley & Sons Inc.",

}

TY - JOUR

T1 - Influence of the route of administration on targetting of ovarian cancer with chimeric monoclonalantibody Mov18: the intravenous versus intraperitoneal route

AU - van Zanten-Przybysz, I.

AU - Molthoff, C.F.

AU - Roos, J.C.

AU - Verheijen, RHM

AU - van Hof, A.

AU - Buist, M.R.

AU - Prinssen, H.M.

AU - den Hollander, W.

AU - Kenemans, P.

PY - 2001

Y1 - 2001

M3 - Letter

SN - 0020-7136

VL - 92

SP - 106

EP - 114

JO - International Journal of Cancer

JF - International Journal of Cancer

ER -